Yikilmaz, T.N. et al. 2016. Clinical Use of Tumor Markers for the Detection and Prognosis of Bladder Carcinoma: A Comparison of CD44, Cytokeratin 20 and Survivin. Urology Journal. 13, 3 (Jun. 2016), 2677–2683. DOI:https://doi.org/10.22037/uj.v13i3.3294.